Publications

Showing entries 1 - 20 out of 101

2023


Fetahu IS, Esser-Skala W, Dnyansagar R, Sindelar S, Rifatbegovic F, Bileck A et al. Single-cell transcriptomics and epigenomics unravel the role of monocytes in neuroblastoma bone marrow metastasis. Nature Communications. 2023 Dec;14(1):3620. doi: 10.1038/s41467-023-39210-0

Baier D, Mendrina T, Schoenhacker-Alte B, Pirker C, Mohr T, Rusz M et al. The Lipid Metabolism as Target and Modulator of BOLD-100 Anticancer Activity: Crosstalk with Histone Acetylation. Advanced science. 2023 Nov 14;10(32):2301939. doi: 10.1002/advs.202301939

Zappe K, Kopic A, Scheichel A, Schier AK, Schmidt LE, Borutzki Y et al. Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter ABCA7 in Breast Cancer. Cells. 2023 Jun;12(11):1462. doi: 10.3390/cells12111462

Hofbauer TM, Distelmaier K, Muqaku B, Spinka G, Seidl V, Arfsten HT et al. Metabolomics implicate eicosanoids in severe functional mitral regurgitation. ESC Heart Failure. 2023 Feb;10(1):311-321. Epub 2022 Oct 10. doi: 10.1002/ehf2.14160

Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A et al. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. Iscience. 2023 Jan 20;26(1):105717. doi: 10.1016/j.isci.2022.105717

Fuchs V, Cseh K, Hejl M, Vician P, Neuditschko B, Meier-Menches SM et al. Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in Mice. Chemistry: A European Journal. 2023 Jan 18;29(4):e202202648. doi: 10.1002/chem.202202648

2022


Neuditschko B, King AP, Huang Z, Janker L, Bileck A, Borutzki Y et al. An Anticancer Rhenium Tricarbonyl Targets Fe-S Cluster Biogenesis in Ovarian Cancer Cells. Angewandte Chemie (International Edition). 2022 Oct 24;61(43):e202209136. doi: 10.1002/anie.202209136

Prechova M, Adamova Z, Schweizer AL, Maninova M, Bauer A, Kah D et al. Plectin-mediated cytoskeletal crosstalk controls cell tension and cohesion in epithelial sheets. Journal of Cell Biology. 2022 Feb 9;221(3):e202105146. doi: 10.1083/jcb.202105146

Meier-Menches SM, Neuditschko B, Janker L, Gerner MC, Schmetterer KG, Reichle A et al. A Proteomic Platform Enables to Test for AML Normalization In Vitro. Frontiers in Chemistry. 2022 Feb 1;10:826346. doi: 10.3389/fchem.2022.826346

Baier D, Schönhacker-Alte B, Rusz M, Pirker C, Mohr T, Mendrina T et al. The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation. Pharmaceutics. 2022 Jan 20;14(2):238. doi: 10.3390/pharmaceutics14020238

2021


Ozenil M, Skos L, Roller A, Gajic N, Holzer W, Spreitzer H et al. Unexpected scaffold rearrangement product of pirenzepine found in commercial samples. Scientific Reports. 2021 Dec 3;11(1):23397. doi: 10.1038/s41598-021-02732-y

Brunmair J, Gotsmy M, Niederstaetter L, Neuditschko B, Bileck A, Slany A et al. Finger sweat analysis enables short interval metabolic biomonitoring in humans. Nature Communications. 2021 Oct 13;12(1):5993. doi: 10.1038/s41467-021-26245-4


Babak MV, Chong KR, Rapta P, Zannikou M, Tang HM, Reichert L et al. Interfering with Metabolic Profile of Triple-Negative Breast Cancers Using Rationally Designed Metformin Prodrugs. Angewandte Chemie (International Edition). 2021 Jun 7;60(24):13405-13413. doi: 10.1002/anie.202102266

Lin Y-S, Weibel J, Landolt H-P, Santini F, Meyer M, Brunmair J et al. Daily Caffeine Intake Induces Concentration-Dependent Medial Temporal Plasticity in Humans: A Multimodal Double-Blind Randomized Controlled Trial. Cerebral Cortex. 2021 Jun;31(6):3096-3106. doi: 10.1093/cercor/bhab005

Showing entries 1 - 20 out of 101